Skip to content
Diatrizoate meglumine
Cystografin, Gastrografin, Hypaque, Md, Sinografin, Urovist (diatrizoate meglumine) is a small molecule pharmaceutical. Diatrizoate meglumine was first approved as Cystografin on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Cystografin (discontinued: Angiovist, Cardiografin, Hypaque, Md, Reno, Urovist, Urovist cysto)
Combinations
Gastrografin (generic drugs available since 1982-01-01, discontinued: Angiovist, Gastrovist, Hypaque, Md, Md-76r, Renocal, Renografin, Renovist, Sinografin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Diatrizoate meglumine
Tradename
Company
Number
Date
Products
CYSTOGRAFIN DILUTEBracco DiagnosticsN-010040 RX1982-11-09
1 products, RLD
CYSTOGRAFINBracco DiagnosticsN-010040 RX1982-01-01
1 products, RLD
Show 7 discontinued
Diatrizoate meglumine
+
Diatrizoate sodium
Tradename
Company
Number
Date
Products
GASTROGRAFINBracco DiagnosticsN-011245 RX1982-01-01
1 products, RLD, RS
Show 7 discontinued
Diatrizoate meglumine
+
Iodipamide meglumine
Tradename
Company
Number
Date
Products
SINOGRAFINBracco DiagnosticsN-011324 DISCN1982-01-01
1 products, RLD
Hide discontinued
Diatrizoate sodium
Tradename
Company
Number
Date
Products
HYPAQUEGE HealthcareN-009561 DISCN1982-01-01
1 products
HYPAQUE SODIUM 20%GE HealthcareN-009561 DISCN1982-01-01
1 products
HYPAQUEGE HealthcareN-009561 DISCN1982-01-01
1 products
HYPAQUEGE HealthcareN-011386 DISCN1982-01-01
2 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
cystografinNew Drug Application2018-04-15
diatrizoate meglumine and diatrizoate sodiumANDA2020-10-22
gastrografinNew Drug Application2021-10-04
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08A: X-ray contrast media, iodinated
— V08AA: Watersoluble, nephrotropic, high osmolar x-ray contrast media
— V08AA01: Diatrizoic acid
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDIATRIZOATE MEGLUMINE
INNsodium amidotrizoate
Description
Amidotrizoic acid is a member of the class of benzoic acids that is benzoic acid having iodo substituents at the 2-, 4- and 6-positions and acetamido substituents at the 3- and 5-positions. It is used, mainly as its N-methylglucamine and sodium salts, as an X-ray contrast medium in gastrointestinal studies, angiography, and urography. It has a role as a radioopaque medium, an environmental contaminant and a xenobiotic. It is an organoiodine compound, a member of benzoic acids and a member of acetamides. It is a conjugate acid of an amidotrizoic acid anion.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Identifiers
PDB—
CAS-ID117-96-4
RxCUI1546223
ChEMBL IDCHEMBL1200839
ChEBI ID31812
PubChem CID2140
DrugBankDB00271
UNII IDV5403H8VG7 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 29,519 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1 adverse events reported
View more details